Kestra Advisory Services’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,500
| Closed | -$23.3K | – | 2833 |
|
|
2024
Q4 | $23.3K | Buy |
31,500
+16,000
| +103% | +$11.8K | ﹤0.01% | 2620 |
|
|
2024
Q3 | $24.3K | Hold |
15,500
| – | – | ﹤0.01% | 2512 |
|
|
2024
Q2 | $26K | Buy |
15,500
+1,000
| +7% | +$1.68K | ﹤0.01% | 2574 |
|
|
2024
Q1 | $34.8K | Buy |
+14,500
| New | +$34.8K | ﹤0.01% | 2415 |
|
|
2023
Q3 | – | Sell |
-14,257
| Closed | -$32.6K | – | 2181 |
|
|
2023
Q2 | $32.6K | Buy |
+14,257
| New | +$32.6K | ﹤0.01% | 2063 |
|